- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03431376
Potato Consumption and Risk of Hypertension
February 12, 2018 updated by: Yu Zhang, Zhejiang University
Potato Consumption Is Prospectively Associated With Risk of Hypertension: An 11.3-year Longitudinal Cohort Study
Government has popularized potatoes as a major staple food in China.
Potato, a potassium-rich food with high glycemic responses after consumption, exhibits unclear effects on hypertension.
In this study, the investigators aimed to examine the association between potato consumption and hypertension risk among Chinese people.
Study Overview
Status
Completed
Conditions
Detailed Description
Potato is considered as a superior crop due to its significant nutritive value and great production yield.
China is the largest potato producer with a quarter of world production, followed by India, Russia, and USA.
The potato production as well as consumption has enhanced in developing countries while continuously declined in developed countries during the last decade.
The investigators therefore explored the prospective associations of consumption of total potatoes, sweet potatoes, stir-fried potatoes, and non stir-fried potatoes with the risk of hypertension in general people of the China Health and Nutrition Survey (CHNS) cohort study from 1989 to 2011.
A total of 11,763 participants (≥20 years old) who were free of hypertension at baseline were enrolled from CHNS Cohort study.
Cox proportional hazards regression models were used to estimate the associations after adjusting for potential confounders.
This study provides new evidence on the association of various potato consumption with the incidence of hypertension in China.
As urbanization accelerates across the whole domain of China, the tendency of transition to Western-style diets and lifestyles appears continuously and steeply growing.
More and more potatoes will be consumed as processed potato products including potatoes chips and French fries, which may be a potential risk factor of hypertension occurrence.
Study Type
Observational
Enrollment (Actual)
11763
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 93 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Of the 11,763 participants, 5,344 male and 6,419 female were enrolled, ranging from 20 to 93 years old.
People who consumed the potatoes, sweet potatoes, stir-fried potatoes, and non stir-fried potatoes accounted for 57.3%, 15.0%, 51.8%, and 28.1%, respectively.
There were about 90.4% people who consumed the potatoes through the stir-frying method.
Description
Inclusion Criteria:
- Adults aged 20-93 with complete data on diet and follow-up time
- Adults with no chronic disease history
Exclusion Criteria:
- Adults aged < 20 years
- Identified to be pregnant
- Previously diagnosed with hypertension, cancers, infarction, apoplexy, and diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hypertension
Time Frame: From entry into the study (baseline: 1989-2009) until 2011
|
Incidence of hypertension, on basis of self-reported physician diagnosis, systolic blood pressure ≥ 140 mm Hg, diastolic blood pressure ≥ 90 mm Hg, or previous diagnose of hypertension by a physician or current use of anti-hypertensive drugs
|
From entry into the study (baseline: 1989-2009) until 2011
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Potato consumption
Time Frame: From entry into the study (baseline: 1989-2009) until 2011
|
The frequency and the quantity of daily average consumption of total potatoes, sweet potatoes, stir-fried potatoes, and non stir-fried potatoes (g/day) based on 3-day 24-hr recall
|
From entry into the study (baseline: 1989-2009) until 2011
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 1989
Primary Completion (Actual)
December 31, 2011
Study Completion (Actual)
February 1, 2018
Study Registration Dates
First Submitted
February 2, 2018
First Submitted That Met QC Criteria
February 12, 2018
First Posted (Actual)
February 13, 2018
Study Record Updates
Last Update Posted (Actual)
February 13, 2018
Last Update Submitted That Met QC Criteria
February 12, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Potato-CHNS-Cohort
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate